Press release
Exosome Therapeutics Pipeline Insights Industry Intelligence: Clinical Trials, Approvals & Emerging Therapies
Exosome Therapeutics Pipeline Insights Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/exosome-therapeutics-pipeline-insights?kb
Cinical Phases/Trials
Rion Inc. is advancing its exosome-based therapy PEP (Purified Exosome Product), currently in Phase II trials for Diabetic Foot Ulcers (DFU). The treatment aims to accelerate wound healing by promoting tissue regeneration and reducing inflammation. Early clinical data have shown promising results in improving ulcer closure rates.
AEGLE Therapeutics is progressing its investigational therapy AGLE-102, now in Phase I/II for Epidermolysis Bullosa (EB), a rare genetic skin disorder. The exosome-based treatment targets enhanced skin repair and reduced blistering, offering a novel, non-gene therapy approach for patients with limited treatment options.
Direct Biologics LLC has advanced its lead candidate ExoFlo to Phase III trials for Acute Respiratory Distress Syndrome (ARDS) after demonstrating strong safety and efficacy in Phase II. ExoFlo, derived from bone marrow mesenchymal stem cells, utilizes extracellular vesicles to modulate inflammation and promote lung tissue recovery.
Key Players:
Rion Inc., AEGLE Therapeutics, Direct Biologics LLC, Kimera Labs
Key Industry Developments:
In May 2025, Kimera Labs, a leading innovator in therapeutic exosome biotechnology, was named a semifinalist in the $101 million XPRIZE Healthspan competition, recognizing its groundbreaking work in developing exosome-based therapies aimed at extending human healthspan and enhancing quality of life.
In July 2023, Direct Biologics, LLC, a late-stage biotech firm specializing in extracellular vesicle (EV)-based regenerative medicine from bone marrow mesenchymal stem cells (BM-MSCs), reported positive Phase 2 clinical trial (NCT04493242) results for ExoFlo. The therapy showed strong safety and notable efficacy in treating hospitalized COVID-19 patients suffering from moderate-to-severe acute respiratory distress syndrome (ARDS).
Growth Forecast Projected:
The Global Exosome Therapeutics Pipeline Insights Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Exosome Therapeutics Pipeline Insights Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=cosmetic-surgery-market?kb
Key Segments:
By Source Type: Mesenchymal Stem Cell (MSC)-Derived Exosomes, Dendritic Cell-Derived Exosomes, Platelet-Derived Exosomes, Epithelial Cell-Derived Exosomes, Other Sources (e.g., immune cells, tumor cells)
By Application: Indication, Oncology (e.g., breast cancer, lung cancer), Neurology (e.g., Alzheimer's disease, stroke), Cardiovascular Diseases, Dermatology & Wound Healing (e.g., diabetic foot ulcers, epidermolysis bullosa), Infectious Diseases (e.g., COVID-19, ARDS), Orthopedic & Regenerative Medicine, Others (e.g., metabolic and autoimmune disorders)
By Therapeutic Modality: Exosome-Based Drugs, Exosome-Loaded Therapeutics (e.g., RNA, proteins, small molecules), Exosome-Mediated Gene Therapy, Exosome-Derived Vaccines
By Route of Administration: Intravenous (IV), Topical / Local Application, Intramuscular, Inhalation / Intranasal, Oral / Subcutaneous
By Development Stage: Preclinical, Phase I, Phase II, Phase III, , By End User, Hospitals & Specialty Clinics, Research & Academic Institutes, Biopharmaceutical Companies
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Exosome Therapeutics Pipeline Insights producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Exosome Therapeutics Pipeline Insights revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/exosome-therapeutics-pipeline-insights?kb
FAQ's
Q: Which regions are dominating the Exosome Therapeutics Pipeline Insights Market and which are fastest-growing?
A: North America dominating the Exosome Therapeutics Pipeline Insights market.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/exosome-therapeutics-pipeline-insights?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exosome Therapeutics Pipeline Insights Industry Intelligence: Clinical Trials, Approvals & Emerging Therapies here
News-ID: 4248951 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Smart Factory Market to Reach US$ 290.6 Billion by 2033 at 12.6% CAGR; North Ame …
The Global Smart Factory Market reached US$ 112.4 billion in 2024 and is expected to reach US$ 290.6 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. Market growth is driven by increasing adoption of Industry 4.0 practices, rising demand for automation and operational efficiency, and growing integration of digital technologies across manufacturing industries.
Smart factories leverage advanced technologies such as the Industrial Internet of Things…
Radiofrequency Ablation Devices Market to Reach US$ 13.54 Billion by 2033 at 10. …
The Global Radiofrequency Ablation Devices Market reached US$ 5.63 billion in 2024 and is expected to reach US$ 13.54 billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic pain conditions and cancer, increasing preference for minimally invasive procedures, and advancements in ablation technologies.
Radiofrequency ablation devices are used to treat tumors, cardiac arrhythmias, and chronic pain…
Mobile Threat Defense (MTD) Market to Reach US$ 10.5 Billion by 2030, Growing at …
According to DataM Intelligence, the global Mobile Threat Defense (MTD) market reached US$ 2.2 billion in 2022 and is expected to reach US$ 10.5 billion by 2030, growing at a CAGR of 22.0% during the forecast period 2024-2031. This growth is propelled by the rapid surge in mobile malware, phishing, and ransomware attacks targeting enterprises, increasing adoption of BYOD and remote work policies, strong demand for cloud-based MTD solutions, rising…
Digital Identity Solutions Market to Reach US$ 189.92 Billion by 2033 at 20.45% …
The Global Digital Identity Solutions Market reached US$ 35.50 billion in 2023 and increased to US$ 42.45 billion in 2024, and is expected to reach US$ 189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033. Market growth is driven by the rising need for secure identity verification, increasing digitalization across industries, and growing concerns over identity fraud and data security.
Digital identity solutions enable the…
More Releases for Exosome
Spotlight on Exosome Delivery Technology - Creative Biolabs Showcased at the 202 …
On September 25, 2025, the multi-day 7th Exosome-Based Therapeutic Development Summit concluded successfully.
New York, USA - October 13, 2025 - During the presentations and panel discussions, participants noted the special benefits exosomes bring-including excellent biocompatibility, low immunogenicity, and the ability to cross biological barriers-reiterating their great promise in cancer treatment, neurological disorders, and immune regulation. When compared with liposomes and traditional nanoparticles, exosomes offer greater efficiencies in carrying nucleic acids,…
Emerging Trends to Reshape the Exosome Technologies Market: Creative Biolabs Lau …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Exosome Technologies Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the exosome technologies market size has seen a significant exponential growth. The market is projected to expand from $0.07 billion in 2024 to $0.09 billion in 2025, with a compound…
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagno …
HTF MI recently introduced Global Exosome Therapy Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborating market size (2024-2031). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
The Major Players Covered in this Report: Sistemic Ltd Aethlon Medical, Inc. (United States), Exosome Diagnostic, Inc. (United States), Thermo Fisher Scientific, Inc. (United…
Exosome Innovations Transforming Healthcare Solutions
The global exosome diagnostic and therapeutic market is witnessing remarkable growth, with its projected value reaching an astounding USD 22,609.77 million by 2034, up from USD 33.04 million in 2023. This meteoric rise represents a staggering compound annual growth rate (CAGR) of 81.03% from 2024 to 2034. As the market continues to expand, the spotlight is firmly on exosomes, small extracellular vesicles that play a significant role in a variety…
Exosome Technologies Market Report 2024 - Exosome Technologies Market Size, Shar …
"The Business Research Company recently released a comprehensive report on the Global Exosome Technologies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The exosome technologies market size…
Exosome technologies Market Growth Expected to See Next Level | Exosome Diagnost …
The Latest Study Published by HTF MI Research on the "Exosome technologies Market'' evaluates market size, trend and forecast to 2030. The Exosome technologies market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges as well…
